<?xml version='1.0' encoding='utf-8'?>
<document id="23720652"><sentence text="Non-steroidal anti-inflammatory drugs do not influence the urinary testosterone/epitestosterone glucuronide ratio."><entity charOffset="67-79" id="DDI-PubMed.23720652.s1.e0" text="testosterone" /><entity charOffset="80-107" id="DDI-PubMed.23720652.s1.e1" text="epitestosterone glucuronide" /><pair ddi="false" e1="DDI-PubMed.23720652.s1.e0" e2="DDI-PubMed.23720652.s1.e0" /><pair ddi="false" e1="DDI-PubMed.23720652.s1.e0" e2="DDI-PubMed.23720652.s1.e1" /></sentence><sentence text="The UDP Glucuronosyl Transferase (UGT) enzymes are important in the pharmacokinetics, and conjugation, of a variety of drugs including non-steroidal anti-inflammatory drugs (NSAIDs) as well as anabolic androgenic steroids (AAS)"><entity charOffset="213-221" id="DDI-PubMed.23720652.s2.e0" text="steroids" /></sentence><sentence text=" Testosterone glucuronidation capacity is strongly associated with a deletion polymorphism in the UGT2B17 gene"><entity charOffset="1-13" id="DDI-PubMed.23720652.s3.e0" text="Testosterone" /></sentence><sentence text=" As the use of high doses of NSAIDs has been observed in athletes there is a risk for a drug-drug interaction that may influence the doping tests for AAS" /><sentence text=" In vitro studies show inhibitory potential on UGT2B7, 2B15, and 2B17 enzymes by NSAIDs" /><sentence text=" The aim of this study was to investigate if concomitant use of NSAIDs and a single dose of testosterone enanthate would affect the excretion rate of testosterone and epitestosterone glucuronide (TG and EG) as well as the T/E ratio, thereby affecting the outcome of the testosterone doping test"><entity charOffset="92-114" id="DDI-PubMed.23720652.s6.e0" text="testosterone enanthate" /><entity charOffset="150-162" id="DDI-PubMed.23720652.s6.e1" text="testosterone" /><entity charOffset="167-194" id="DDI-PubMed.23720652.s6.e2" text="epitestosterone glucuronide" /><entity charOffset="196-198" id="DDI-PubMed.23720652.s6.e3" text="TG" /><entity charOffset="203-205" id="DDI-PubMed.23720652.s6.e4" text="EG" /><entity charOffset="270-282" id="DDI-PubMed.23720652.s6.e5" text="testosterone" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e0" e2="DDI-PubMed.23720652.s6.e0" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e0" e2="DDI-PubMed.23720652.s6.e1" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e0" e2="DDI-PubMed.23720652.s6.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e0" e2="DDI-PubMed.23720652.s6.e3" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e0" e2="DDI-PubMed.23720652.s6.e4" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e0" e2="DDI-PubMed.23720652.s6.e5" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e1" e2="DDI-PubMed.23720652.s6.e1" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e1" e2="DDI-PubMed.23720652.s6.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e1" e2="DDI-PubMed.23720652.s6.e3" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e1" e2="DDI-PubMed.23720652.s6.e4" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e1" e2="DDI-PubMed.23720652.s6.e5" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e2" e2="DDI-PubMed.23720652.s6.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e2" e2="DDI-PubMed.23720652.s6.e3" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e2" e2="DDI-PubMed.23720652.s6.e4" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e2" e2="DDI-PubMed.23720652.s6.e5" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e3" e2="DDI-PubMed.23720652.s6.e3" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e3" e2="DDI-PubMed.23720652.s6.e4" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e3" e2="DDI-PubMed.23720652.s6.e5" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e4" e2="DDI-PubMed.23720652.s6.e4" /><pair ddi="false" e1="DDI-PubMed.23720652.s6.e4" e2="DDI-PubMed.23720652.s6.e5" /></sentence><sentence text=" The study was designed as an open, randomized, cross-over study with subjects being their own control" /><sentence text=" The 23 male healthy volunteers, with either two, one or no allele (ins/ins, ins/del, or del/del) of the UGT2B17 gene, received the maximum recommended dose of NSAID (Ibuprofen or Diclofenac) for 6 days"><entity charOffset="167-176" id="DDI-PubMed.23720652.s8.e0" text="Ibuprofen" /><entity charOffset="180-190" id="DDI-PubMed.23720652.s8.e1" text="Diclofenac" /><pair ddi="false" e1="DDI-PubMed.23720652.s8.e0" e2="DDI-PubMed.23720652.s8.e0" /><pair ddi="false" e1="DDI-PubMed.23720652.s8.e0" e2="DDI-PubMed.23720652.s8.e1" /></sentence><sentence text=" On day three, 500 mg of testosterone enanthate was administered"><entity charOffset="25-47" id="DDI-PubMed.23720652.s9.e0" text="testosterone enanthate" /></sentence><sentence text=" Spot urine samples were collected for 17 days" /><sentence text=" After a wash-out period of 4 months the volunteers received 500 mg testosterone enanthate only, with subsequent spot urine collection for 14 days"><entity charOffset="68-90" id="DDI-PubMed.23720652.s11.e0" text="testosterone enanthate" /></sentence><sentence text=" The glucuronides of testosterone and epitestosterone were quantified"><entity charOffset="5-17" id="DDI-PubMed.23720652.s12.e0" text="glucuronides" /><entity charOffset="21-33" id="DDI-PubMed.23720652.s12.e1" text="testosterone" /><entity charOffset="38-53" id="DDI-PubMed.23720652.s12.e2" text="epitestosterone" /><pair ddi="false" e1="DDI-PubMed.23720652.s12.e0" e2="DDI-PubMed.23720652.s12.e0" /><pair ddi="false" e1="DDI-PubMed.23720652.s12.e0" e2="DDI-PubMed.23720652.s12.e1" /><pair ddi="false" e1="DDI-PubMed.23720652.s12.e0" e2="DDI-PubMed.23720652.s12.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s12.e1" e2="DDI-PubMed.23720652.s12.e1" /><pair ddi="false" e1="DDI-PubMed.23720652.s12.e1" e2="DDI-PubMed.23720652.s12.e2" /></sentence><sentence text=" NSAIDs did not affect the excretion of TG or EG before the administration of testosterone"><entity charOffset="78-90" id="DDI-PubMed.23720652.s13.e0" text="testosterone" /><entity charOffset="40-51" id="DDI-PubMed.23720652.s13.e1" text="TG" /><entity charOffset="46-57" id="DDI-PubMed.23720652.s13.e2" text="EG" /><pair ddi="false" e1="DDI-PubMed.23720652.s13.e1" e2="DDI-PubMed.23720652.s13.e1" /><pair ddi="false" e1="DDI-PubMed.23720652.s13.e1" e2="DDI-PubMed.23720652.s13.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s13.e1" e2="DDI-PubMed.23720652.s13.e0" /><pair ddi="false" e1="DDI-PubMed.23720652.s13.e2" e2="DDI-PubMed.23720652.s13.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s13.e2" e2="DDI-PubMed.23720652.s13.e0" /></sentence><sentence text=" The concomitant use of NSAIDs and testosterone slightly increased the TG excretion while the EG excretion was less suppressed compared to testosterone use only"><entity charOffset="35-47" id="DDI-PubMed.23720652.s14.e0" text="testosterone" /><entity charOffset="139-151" id="DDI-PubMed.23720652.s14.e1" text="testosterone" /><entity charOffset="71-82" id="DDI-PubMed.23720652.s14.e2" text="TG" /><entity charOffset="94-105" id="DDI-PubMed.23720652.s14.e3" text="EG" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e0" e2="DDI-PubMed.23720652.s14.e0" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e0" e2="DDI-PubMed.23720652.s14.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e0" e2="DDI-PubMed.23720652.s14.e3" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e0" e2="DDI-PubMed.23720652.s14.e1" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e2" e2="DDI-PubMed.23720652.s14.e2" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e2" e2="DDI-PubMed.23720652.s14.e3" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e2" e2="DDI-PubMed.23720652.s14.e1" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e3" e2="DDI-PubMed.23720652.s14.e3" /><pair ddi="false" e1="DDI-PubMed.23720652.s14.e3" e2="DDI-PubMed.23720652.s14.e1" /></sentence><sentence text=" The effects of the NSAIDs on the TG and EG excretion did not differ between the UGT2B17 genotype groups"><entity charOffset="34-35" id="DDI-PubMed.23720652.s15.e0" text="TG" /><entity charOffset="41-42" id="DDI-PubMed.23720652.s15.e1" text="EG" /><pair ddi="false" e1="DDI-PubMed.23720652.s15.e0" e2="DDI-PubMed.23720652.s15.e0" /><pair ddi="false" e1="DDI-PubMed.23720652.s15.e0" e2="DDI-PubMed.23720652.s15.e1" /></sentence><sentence text=" In conclusion, the outcome of testosterone doping tests does not seem to be affected by the use of NSAIDs"><entity charOffset="31-43" id="DDI-PubMed.23720652.s16.e0" text="testosterone" /></sentence><sentence text="" /></document>